RADBIO Alternatives & Competitors
12 companies similar to RADBIO — Developing a therapeutic platform targeting TGF-beta, the "master regulator of f...
Companies similar to RADBIO
RiboNova, Inc.
Focused on Mitochondrial Disease & other serious rare diseases. R007 is our P2 ready asset...
SonoThera
SonoThera is developing ultrasound-mediated nonviral genetic therapies.
Kelonia Therapeutics
Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines.
Zelluna Immunotherapy
Developing allogeneic TCR-NK therapies for solid tumors
Rival Readout
Competing with RADBIO? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Janux Therapeutics
Developing unique immunotherapies that generate tumor-specific immune responses to attack...
A2 Biotherapeutics, Inc.
Powerful & precise T cell therapy that attacks solid tumors while sparing normal cells.
Pliant Therapeutics
We are transforming the lives of patients by developing best-in-class treatments for fibro...
MDI Therapeutics, Inc.
Developing novel serpin-based therapies
Lisata Therapeutics, Inc.
Targeted Therapy Delivered
ImmunoBiochem Corporation
Improving patient outcomes through innovations in biological therapeutics
Hercules Pharmaceuticals
Driving Innovation in Non-Toxic Oral Therapies for Triple Negative Breast Cancer and Solid...
AlgiPharma AS
A biopharmaceutical company with a focus on developing its first drug candidate for patien...
About RADBIO
RADBIO is a biopharmaceutical startup focusing on developing a therapeutic platform targeting TGF-beta, known as the "master regulator of fibrosis." Fibrosis, a significant factor in the cause of death for many diseases, lacks effective treatments to halt or reverse its progression, despite existing drugs that can dela...
Therapeutic Platform, TGF-beta, Fibrosis Treatment, Genetic Engineering, Drug Development, Biomolecule Therapy, Research And Development, Biomarkers, Biopharmaceutical, Diagnosis, Solid Tumors, Neutralizing Biomolecule, Delivery Strategies
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around RADBIO: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at RADBIO on 27 Oct 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.